Consultant Dr Luke Moore and colleagues, has had an article published in The Journal of Antimicrobial Chemotherapy: COVID-19 and the potential long-term impact on antimicrobial resistance.
The Journal of Antimicrobial Chemotherapy is a journal of the British Society for Antimicrobial Chemotherapy (BSAC) and is among the foremost international journals in antimicrobial research. The readership includes representatives of academia, industry and health services, and includes those who are influential in formulary decisions.
Click here to read the article in the Journal of Antimicrobial Chemotherapy